Forest Laboratories is in the final stages of negotiations to buy specialty pharmaceutical company Aptalis Holdings for roughly $3 billion, said people familiar with the matter.
Forest Laboratories near $3 billion acquisition of Aptalis
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.